Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Generation Bio (GBIO)

  • Technical Exchange News
  • March 04, 2025, 02:42 UTC
  • 17

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CytomX Therapeutics Inc (CTMX)

  • Technical Exchange News
  • March 04, 2025, 02:42 UTC
  • 17

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Acurx Pharmaceuticals Inc. (ACXP)

  • Technical Exchange News
  • March 04, 2025, 02:42 UTC
  • 17

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

iBio Inc. (IBIO)

  • Technical Exchange News
  • March 04, 2025, 01:00 UTC
  • 16

NASDAQ traded attribute type Security_Name was changed. Previous value: iBio, Inc. Common Stock. New value: iBio, Inc. Common Stock.

Comment Full text

iBio Inc. (IBIO)

  • Technical Exchange News
  • March 04, 2025, 01:00 UTC
  • 19

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: iBio, Inc. Common Stock.

Comment Full text

iBio Inc. (IBIO)

  • Technical Exchange News
  • March 04, 2025, 01:00 UTC
  • 15

NASDAQ traded attribute type Financial_Status was changed. Previous value: . New value: iBio, Inc. Common Stock.

Comment Full text

Rallybio Corporation (RLYB)

  • Technical Exchange News
  • March 03, 2025, 18:50 UTC
  • 19

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Outset Medical Inc. (OM)

  • Technical Exchange News
  • March 03, 2025, 18:50 UTC
  • 20

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Generation Bio (GBIO)

  • Technical Exchange News
  • March 03, 2025, 18:49 UTC
  • 19

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CytomX Therapeutics Inc (CTMX)

  • Technical Exchange News
  • March 03, 2025, 18:49 UTC
  • 20

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 114
  • 115
  • 116
  • 117
  • 118
  • Next

Search

News categories

  • Technical Exchange News(9551)
  • Event(407)
  • SEC News(156644)
  • FDA Approval(8944)
  • Company Report(721)
  • Business News(106282)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin